Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, Y.-M. A.
Right arrow Articles by Sando, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, Y.-M. A.
Right arrow Articles by Sando, J. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 48, 34036-34044, November 26, 1999


Lipid-dependent Activation of Protein Kinase C-alpha by Normal Alcohols*

Yu-Ming A. ShenDagger , Olga I. Chertihin, Rodney L. Biltonen, and Julianne J. Sando§

From the Department of Pharmacology and the Biophysics Program and the Cancer Center, The University of Virginia Health Sciences Center, Charlottesville, Virginia 22903

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Significant stimulation of protein kinase C-alpha (PKCalpha ) by n-alcohols was observed in characterized lipid systems composed of phosphatidylcholine/phosphatidylserine/dioleoylglycerol (PC/PS/DO). The logarithm of the alcohol concentrations to achieve half-maximal PKC stimulation (ED50) and of the maximal PKC stimulation by alcohols were both linear functions of alcohol chain length, consistent with the Meyer-Overton effect. Binding of phorbol esters to PKC was not significantly affected by octanol. Octanol increased, up to 4-fold, the affinity of PKC binding to the lipid bilayers in both the absence and presence of DO. However, octanol increased PKC activity much more significantly than it enhanced binding of the enzyme to the lipid bilayers, suggesting that the stimulation of PKC is not merely a reflection of the increase in PKC bilayer binding affinity. 31P NMR experiments did not reveal formation of non-lamellar phases with octanol. Differential scanning calorimetry suggested that alcohols, like diacylglycerol, induce formation of compositionally distinct domains and the maximal enzyme activity with alcohol resided roughly in the putative domain-coexistence region. These results suggest that alcohols are mimicking diacylglycerol in activating PKC, not by binding to the high affinity phorbol ester binding site, but by altering lipid structure and by enhancing PKC-bilayer binding.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Despite extensive research in the past century, the mechanism of anesthesia is not well understood and the site(s) of action of anesthetics is still open to question (1, 2). A common feature of anesthetic action is the modulation of electrical signaling which is accomplished by altering membrane conductance through ion channels or ion channel-linked receptors (3). Two general hypotheses are proposed to account for the anesthetic actions on these membrane-associated protein systems (1, 3, 4). The protein binding hypothesis argues that anesthetics bind directly to hydrophobic regions of specific protein receptors. The membrane perturbation hypothesis argues that anesthetics alter physical properties of the membrane that are necessary for the normal operation of various membrane-associated proteins.

Protein kinase C (PKC)1 phosphorylates and regulates many of the membrane proteins that have been implicated in pathways affected by anesthetics (5-8), and both general and local anesthetics have been shown to modulate PKC activity (9-12). Moreover, PKC requires amphipathic molecules like diacylglycerol (DAG) and phosphatidylserine (PS) as cofactors that may activate PKC by both direct binding and by altering the physical properties of the membrane. Many anesthetics are amphipathic molecules which have been proposed to bind to PKC at certain sites (10) as well as to perturb the lipids in the bilayer (3). Thus PKC is a potential target of anesthetic action and a model protein for testing both the protein binding hypothesis and the membrane perturbation hypothesis.

PKC is a family of membrane-associated, serine/threonine kinases present in all tissues and especially abundant in the central nervous system (13). The PKC family consists of at least 11 isozymes which require negatively charged phospholipids (among which PS is much more effective than others), and for some of them, DAG and Ca2+ to achieve full activation (14). Phorbol esters can replace the DAG requirement (15). In addition, the enzymes can be activated in a lipid-independent manner by protamine sulfate. While the role of cofactors in the PKC activation process is not clearly understood, a variety of studies has argued that physical properties of the lipid bilayers are important for the activation mechanism (16). The physical properties of lipid bilayers that are most important in PKC activation have not been elucidated. Those that have been suggested include lateral heterogeneity or domain formation (17-19), head group spacing (20, 21), lipid bilayer curvature (22), and tendency of the bilayer lipid to form non-bilayer phases (22, 23). The surface potential of lipid bilayers also can influence activation by, for example, sequestering Ca2+ on the membrane surface (24, 25). Since anesthetics can alter many of these membrane properties (12, 26-28), it is our working hypothesis that anesthetics affect PKC activity, at least in part, by their effects on membrane physical properties, and that the anesthetic-modulated enzyme directly or indirectly regulates the ion channels involved in anesthesia.

Effects of anesthetics on PKC activation have been noted since the early 1980s (29), but the mechanism of and even the direction of the effects have remained elusive. Lester and Baumann (30) demonstrated stimulation of PKC by alcohols in the presence of phosphatidylcholine/phosphatidylserine (PC/PS) vesicles (30). Hemmings and Adamo (31) noted that varying anesthetic effects could be obtained in different lipid systems. Slater et al. (32) showed that interaction of n-alcohols and general anesthetics with PKCalpha results in dramatically different effects on protamine sulfate-activated enzyme activity versus lipid activated activity. Furthermore, the effects of the n-alcohols on lipid-associated PKCalpha activity differ markedly depending on whether the activity is induced by diacylglycerol or phorbol ester and are dependent upon n-alcohol chain length (10, 32).

We have examined the effects of several alcohol anesthetics on PKC activity and membrane binding in characterized lipid systems that support PKC activity and mimic many features of the cellular membrane. The saturated lipids DMPC and DMPS were used in this study so that the phase behavior of these defined lipid binary and ternary systems at various alcohol concentrations could be studied by differential scanning calorimetry (DSC). More physiological unsaturated lipid systems also were examined and similar effects were observed. The modulation of PKC activity by alcohols appears to be associated with alcohol effects on lipid structure, possibly via the induction of lateral heterogeneity or domain formation.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- 1,2-Dimyristoyl-sn-glycerol-3-phosphatidylcholine (DMPC), 1,2-dimyristoyl-sn-glycerol-3-phosphatidylserine (DMPS), 1,2-dipalmitoyl-sn-glycerol-3-phosphatidylcholine (DPPC), 1,2-dipalmitoyl-sn-glycerol-3-phosphatidylserine (DPPS), 1-palmitoyl, 2-oleoyl-sn-glycerol-3-phosphatidylcholine (POPC), 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylserine (POPS), 1,2-dioleoyl-sn-glycerol (DO), and dansyl-phosphatidylethanolamine (dansyl-PE) were from Avanti Polar Lipids (Birmingham, AL). All of the lipids were greater than 99% pure as determined by thin-layer chromatography on Adsorbosil-Plus plates from Alltech Associates, Inc. (Deerfield, IL) using the solvent systems described previously (19). MOPS, calcium chloride, potassium chloride, and EGTA were Chemika grade and the magnesium chloride was puriss grade from Fluka Chemical Corp. (Ronkonkoma, NY). [gamma -32P]ATP (7000 Ci/mmol) was from ICN Pharmaceuticals, Inc. (Costa Mesa, CA). [20-3H]Phorbol 12,13-dibutyrate (10-20 Ci/mmol) was from NEN Life Science Products Inc. (Boston, MA). Lysine-rich histone (type III-s), ATP, and phorbol esters were from Sigma. Octanol, heptanol, hexanol, pentanol, and butanol were also from Sigma. Chloroform, methanol, and benzene were high performance liquid chromatography grade from Fisher Scientific Co. (Pittsburgh, PA). Grace's culture medium, yeastolate, lactalbumin, and fetal calf serum for culture of Sf9 insect cells were from Life Technologies, Inc. (Grand Island, NY).

Purification of Protein Kinase C-- Sf9 insect cells (~2 × 106 cells/ml in spinner culture) were infected with a PKCalpha baculovirus expression construct kindly provided by Drs. P. Parker, S. Stabel, and D. Fabbro. Infected cells were harvested when the viability dropped to approximately 85%. PKCalpha was purified from the cytosol by sequential chromatography on Q-Sepharose and phenyl-Sepharose columns, both from Amersham Pharmacia Biotech. Enzyme concentration was determined by assay of phorbol ester binding as described previously (33) and enzyme purity was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by silver staining and Western blotting using PKCalpha -specific rabbit polyclonal antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz. CA). The purified PKCalpha was then stored in 30% glycerol and 20 mM MOPS at -75 °C. Enzyme was thawed and diluted with MOPS/KCl buffer just prior to the kinase assays. The enzyme remained 90% intact after incubation for 1 h at 35 °C as described previously (19).

Preparation of Lipid Vesicles-- The concentration of lipid stock solutions in chloroform was periodically determined by phosphate assay as described previously (34). Phospholipids and DO stored in chloroform were mixed together at the desired molar ratios and dried thoroughly under nitrogen then under vacuum for at least 1 h. The lipids were then lyophilized from benzene/methanol (19/1, v/v) for a minimum of 12 h in the dark. Each dried sample was hydrated in 20 mM MOPS, 100 mM KCl, 100 µM EGTA, pH 7.2 (MOPS/KCl buffer). Each sample was vortexed extensively above the main transition temperature for 20 min to make multilamellar vesicle (MLVs) dispersions. MLVs were subsequently extruded using a hand microextruder (Avanti Polar Lipids) to make large unilamellar vesicles (LUVs), as described (19). All lipid vesicles were stored in the dark under an argon atmosphere at room temperature.

Assay of Protein Kinase C Activity-- Kinase activity was assessed by the ability of the enzyme to incorporate [gamma -32P]ATP into histone. The reaction mixture (75 µl total) contained 5 mM MgCl2, 300 µM CaCl2, 0.2 mg/ml lysine-rich histone, 40 µM ATP spiked with [gamma -32P]ATP to 1.6-3.7 Ci/mmol, 5 nM PKCalpha , 20 mM MOPS, 100 mM KCl, 100 µM EGTA, pH 7.2, 1 mM lipids, and alcohols at concentrations as indicated in the figure legends. The reaction was terminated after 4 min at 35 °C, 5-7 min at 30 °C, or 1 h at 4 °C by spotting 60 µl of the reaction mixture onto Whatman P-81 ion exchange paper (Whatman International, Maidstone, United Kingdom). The papers were washed three times in 50 mM NaCl to remove unreacted ATP and then dried. Bound radioactivity was quantitated by measuring the Cerenkov radiation on a Beckman scintillation counter.

Assay of PKC-Phorbol Ester Binding-- Phorbol ester binding was assessed by the ability of [20-3H]phorbol 12,13-dibutyrate (PDBu) to bind to PKCalpha . The reaction mixture (75 µl total) contained 5 mM MgCl2, 300 µM CaCl2, 1 mg/ml bovine serum albumin, 2 mM dithiothreitol, 40 nM [20-3H]PDBu, MOPS/KCl buffer, 5 nM PKC, 1 mM lipids, with 1.5 µM non-labeled PDBu or 0.15% ethanol vehicle, and alcohols at concentrations as indicated in the figure legends. The reaction was conducted for 5 min at 30 °C or 1 h at 4 °C, and bound [20-3H]PDBu was separated from free PDBu by rapid passage through Whatman 934-AH glass fiber filters. The filters were washed 3 times with iced phosphate-buffered saline (0.15 M NaCl, 8.3 mM NaHPO4, 1.4 mM NaH2PO4), and counted in a Beckman scintillation counter. The specific binding of PDB to PKC was calculated as the difference between binding in the presence and absence of excess unlabeled PDB.

Binding of PKC to the Lipid Bilayers-- Affinity of PKC binding to the lipid bilayers was estimated using fluorescence energy transfer from tryptophans in PKC to a dansyl-PE probe with a SLM 8100 fluorometer (SLM-Aminco, Urbana, IL), as modified from Bazzi and Nelsestuen (35). The excitation and the emission wavelengths were 283 and 510 nm, respectively. Large unilamellar vesicles (LUVs) containing PC/PS/DO and 2 mol % dansyl-PE at various lipid concentrations were incubated with 33 or 67 nM PKC. The experiments were carried out in the same buffer as in the PKC activity assay but histone and ATP were omitted.

31P Nuclear Magnetic Resonance Spectroscopy-- MLVs (20 mM total lipid) were prepared with hydrating buffer containing 50% (v/v) D2O. After a minimum of 2 days of hydration, each sample was transferred to a 10-mm diameter NMR tube (Wilmad Glass Co., Buena, NJ). Proton-decoupled free induction decays were collected at 30 °C using a Varion 500 Unity Plus spectrometer operating at 202.4 MHz with the following instrument settings: sweep width, 30 kHz; pulse width, 20 µs; acquisition time, 0.41 s; receiver delay, 0.65 s; number of transients, 10,800. An exponential multiplication corresponding to line broadening of 10 Hz was applied to the accumulated free induction decays before Fourier transformation.

Differential Scanning Calorimetry-- Excess heat capacity measurements of lipid and lipid-alcohol dispersions (1.4 ml of 5 mM total lipid) were performed on a MicroCal MC-2 (Microcal Inc., Northampton, MA) differential scanning calorimeter at a nominal scan rate of 10 °C/h. The experimental data were analyzed with the MicroCal's Origin graphic software program.

Determination of Partition Coefficient-- Partition coefficients of alcohols in DMPC/DMPS/DO systems were determined by injection titration calorimetry (36) and by measuring the depression of the gel-fluid transition temperature (37), as described elsewhere. Injection titration calorimetry was performed on a MicroCal Omega calorimeter. Solvent blanks or lipids (5 mM) combined with alcohol were injected into alcohol solutions at 35 or 4 °C with an injection volume of 30 µl for a duration of 20 s. The syringe spin rate was 300 rpm. The free alcohol concentration in an alcohol-lipid-water suspension was determined by a solvent null method, heat is absorbed (released) if the free alcohol concentration in the cell is higher (lower) than that in the suspension; when the concentration in the cell matches the free concentration in the suspension, no heat is generated upon mixing. The freezing point depression method was used to obtain the difference between the partition coefficients of the alcohol into lipids in the fluid and gel state, using the transition temperature shift induced by alcohol. The relationship between the difference of partition coefficients and the shift of the phase transition temperature is,
<FR><NU>1</NU><DE>T<SUB>m</SUB><SUP>*</SUP></DE></FR>−<FR><NU>1</NU><DE>T<SUB>m</SUB></DE></FR>=R×(K<SUB>p,f</SUB>−K<SUB>p,g</SUB>)×<FR><NU>X<SUB>a,w</SUB></NU><DE>&Dgr;H<SUP><UP>o</UP></SUP></DE></FR> (Eq. 1)
where Tm and Tm* are the transition temperatures in the absence and presence of alcohol, respectively, Kp,f and Kp,g are the mole fraction partition coefficients of the alcohol in fluid and gel state lipids, respectively; R is the gas constant; Delta H° is the enthalpy per mole of lipid that undergoes a gel to fluid phase transition in the absence of alcohols; Xa,w is the mole fraction of alcohol in the aqueous solution at Tm*.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Alcohols Activate PKC in DMPC/DMPS/DO-- The effect of alcohols on PKC activation was examined first in DMPC/DMPS/DO ((80-X)/20/X). PKC activity increased from 0 to 25-30 mol % DO and decreased above 30 mol % DO (data not shown). Addition of alcohols to this lipid system increased PKC activity (Fig. 1). In the presence of 15 and 25 mol % DO, alcohols activated PKC synergistically with DO until maximal enzyme activity was achieved. With shorter chain alcohols, PKC activation decreased significantly at higher alcohol concentrations (Fig. 1, D and E). Even in the absence of DO, high concentrations of alcohols activated PKC. With longer chain alcohols (Fig. 1, A-C), this activation was greater than that achieved with 25 mol % DO, which maximally activated PKC in the absence of alcohol (see above).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   PKCalpha activity as a function of alcohol concentration in DMPC/DMPS/DO ((80-X)/20/X). PKCalpha activity was assayed in DMPC/DMPS/DO = 80/20/0 (), 65/20/15 (black-triangle), or 55/20/25 (open circle ) MLVs with various concentrations of octanol (A), heptanol (B), hexanol (C), pentanol (D), and butanol (E) at 30 °C for 5 min. The total lipid concentration was 1 mM. PKCalpha activity is expressed as the fold increase in enzyme activity compared with 25 mol % DO in the absence of alcohols. Alcohols were equilibrated with the lipids for at least 12 h before the experiments. Values are means ± S.E. for triplicate determinations from a single experiment representative of two to four independent experiments depending on the alcohol.

The alcohol concentration to achieve half-maximal stimulation of PKC activity (ED50) correlated quantitatively with the chain length of the alcohol (Fig. 2A), with the longer chain alcohols requiring lower concentrations for half-maximal activation of PKC. For each alcohol, the ED50 was smaller in the presence of DO than in the absence of DO, but the slope of the log ED50 versus chain length appeared to be invariant. Since the alcohol chain length correlates linearly with the logarithm of alcohol partition coefficient between lipids and buffer, a quantitative correlation between the ED50 and the partition coefficient of alcohols was obtained as expected (inset of Fig. 2A).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Alcohol concentration for half-maximal PKCalpha stimulation and maximal PKC activity as a function of alcohol carbon chain length. A, the alcohol concentration that half-maximally stimulated PKCalpha (ED50) is shown for DMPC/DMPS/DO = 80/20/0 (), 65/20/15 (black-triangle), or 55/20/25 (open circle ) as a function of alcohol acyl chain length. The ED50 as a function of alcohol partition coefficient is shown in the inset. B, the fold increase in maximal PKC activity with alcohols over that with 25 mol % DO without alcohols is plotted as a function of acyl carbon chain length for DMPC/DMPS/DO = 80/20/0 (), 65/20/15 (black-triangle), and 55/20/25 (open circle ). ED50 and maximal PKCalpha activity for each alcohol were determined from Fig. 1. Membrane/water partition coefficients for alcohols were determined by isothermal titration calorimetry as described under "Experimental Procedures." Lines were calculated by linear regression.

A similar correlation was obtained between the alcohol chain length and the maximal alcohol-enhanced PKC activity, defined as the fold stimulation of maximal PKC activity with alcohol over that with 25 mol % DO without alcohol (Fig. 2B). The maximal alcohol-enhanced PKC activity was greater with higher DO concentrations for individual alcohols, but maximal PKC activity appeared to increase with alcohol chain length more rapidly at lower DO concentrations, as indicated by the increase of the slope when DO mol % was decreased (Fig. 2B).

Octanol Activates PKC in DPPC/DPPS/DO and POPC/POPS/DO Systems-- To determine whether the phospholipid composition, like the DO mol %, affected alcohol activation of PKC, we examined two additional lipid systems. DPPC/DPPS/DO was selected because this system is similar to DMPC/DMPS/DO with saturated acyl chains on the phospholipids, but it provides a gel state environment because its gel-liquid crystalline phase transition occurs at temperatures higher than the PKC activity assay temperature (30 °C). POPC/POPS/DO was selected because this system contains lipids with saturated and unsaturated acyl chains that are similar to cell membrane lipids and exist in the fluid state under our assay conditions. It also has been shown to activate more effectively than DMPC/DMPS/DO at low DO concentrations (20). This system also supports PKC-phorbol ester binding which will be utilized in later experiments whereas neither of the saturated phospholipid systems (DMPC/DMPS or DPPC/DPPS) supports significant phorbol ester binding. We selected octanol as a representative alcohol to use with the two lipid systems because it was the most potent alcohol in stimulating PKC activity in the DMPC/DMPS/DO system.

DPPC/DPPS/DO and POPC/POPS/DO were first characterized for PKC activating ability at various concentrations of DO from 0 to 25 mol % (data not shown). DPPC/DPPS/DO supported PKC activity with increasing DO from 0 to 10 mol %, with maximal PKC activity maintained until 20 mol %. PKC activity decreased when DO was higher than 20 mol %. POPC/POPS/DO required much less DO (1 mol %) to maximally activate PKC, similar to the fully unsaturated DOPC/DOPS/DO system studied previously (20). The enzyme was nearly inactive at 0 mol % DO, then was activated linearly from 0 to 1 mol % DO, and maintained maximal activity from 1 to 25 mol % DO (data not shown).

Addition of octanol to the DPPC/DPPS/DO system enhanced PKC activity similarly to that in DMPC/DMPS/DO (cf. Fig. 1A and Fig. 3A). In the presence of 15 or 25 mol % DO, low concentrations of octanol stimulated PKC activity significantly and synergistically with DO. The stimulation was maximal at 2.5 mM octanol and decreased at higher octanol concentration. As with the DMPC/DMPS system, high octanol concentrations activated PKC in the DPPC/DPPS system in the absence of DO. However, a higher octanol concentration was required to obtain the onset of PKC stimulation in the DPPC/DPPS system in the absence of DO (~2.5 mM octanol for DPPC/DPPS versus ~1 mM octanol for the DMPC/DMPS system).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   PKCalpha activity as a function of octanol concentration in different lipid systems. PKCalpha activity was assayed with various octanol concentrations in: A, DPPC/DPPS/DO = 80/20/0 (), 65/20/15 (black-triangle), or 55/20/25 (open circle ), and B, POPC/POPS/DO = 80/20/0 (), 79.5/20/0.5 (triangle ), or 75/20/5 (black-square) MLVs at 30 °C for 5 min. Total lipid concentration was 1 mM. PKCalpha activity is expressed as the fold increase in the enzyme activity compared with 25 mol % DO for DPPC/DPPS/DO and 5 mol % DO for POPC/POPS/DO in the absence of octanol. Values are mean ± S.E. for triplicate determinations from a single experiment representative of two to four independent experiments.

In the POPC/POPS/DO system (Fig. 3B), PKC activity increased with octanol concentration and did not seem to reach a maximum as observed with the DMPC/DMPS/DO and DPPC/DPPS/DO systems. In both the absence and presence of DO, even the lowest octanol concentrations caused significant increases in PKC activity. The presence of DO provided a small increase in the enzyme activity, but did not alter the dependence of PKC activation on octanol. The synergistic effect of DO and octanol on maximal PKC activation was not as prominent as with the saturated lipid systems.

The effects of alcohols on PKC activation are similar to those of DAG in three respects. First, in the saturated lipid system higher alcohol or DAG concentration is required to significantly activate PKC. Second, the enzyme activity exhibits a maximum as a function of alcohol or DAG concentration. Third, in the unsaturated lipid system much lower concentrations of either alcohol or DAG are required to activate PKC.

Octanol Does Not Affect High Affinity Binding of Phorbol Esters to PKC-- The observation that alcohols activate PKC in the absence of DO raised the possibility that alcohols might activate PKC by interacting with the binding sites for DO on the enzyme, presumably the cysteine-rich domains which also bind phorbol esters with high affinity. To test this hypothesis, we examined the effects of octanol on the binding of phorbol esters to PKC.

In POPC/POPS (50/50) MLVs, PDBu bound to 5 nM PKC with an apparent dissociation binding constant (Kd) of about 20 nM (Fig. 4A). We had to reduce the concentration of POPC from 80 to 50 mol % because we found that the nonspecific binding of PDBu to the membrane was greatly enhanced when POPC is greater than 70% (data not shown). High concentrations of octanol (1 and 2 mM) did not have inhibitory effects on the binding over a range of PDBu concentrations up to 10-fold the apparent Kd (Fig. 4A). Instead, octanol appeared to slightly enhance maximal PDB binding to PKC. To further investigate this enhancement, a series of octanol concentrations were applied to POPC/POPS (50/50) with 75 nM PDBu, under which conditions the high affinity phorbol ester-binding site of PKC was essentially saturated. No significant effect on the degree of PDB-PKC binding was observed (Fig. 4B). The inset of Fig. 4 shows that octanol activated PKC over this alcohol concentration range in this POPC/POPS (50/50) system as it did in POPC/POPS (80/20) (Fig. 3). Similar results were found in the presence of 5 mol % DO (POPC/POPS/DO (45/50/5)) with dramatic activation of PKC by octanol but with no effect on PDB binding to PKC (data not shown). PKC-alpha has a putative second phorbol ester-binding site with a Kd at least 2 orders of magnitude higher than that for the high affinity binding site (38). Due to high nonspecific membrane binding of PDBu at high concentrations, our binding assay was not able to assess low affinity binding of phorbol ester to PKC.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of octanol on the specific binding of phorbol ester to PKCalpha . The specific binding of [3H]PDBu to PKCalpha (5 nM) was determined in POPC/POPS = 50/50 MLVs (1 mM). A, binding of PKCalpha to [3H]PDBu with 0 (), 1 (black-triangle), and 2 mM (open circle ) octanol. The reaction was conducted at 4 °C for 2 h. B, binding of PKC to [3H]PDBu (72 nM) was assayed as a function of octanol concentration at 30 °C for 6 min. The enzyme activity as a function of octanol concentration assayed under the same conditions is shown in the inset. Values are means ± S.E. for four to six replicate determinations from a single experiment representative of three independent experiments.

Octanol Increases Membrane Binding of PKC in the DMPC/DMPS System-- PKC has to be associated with the bilayer to achieve its highest activity. PKC activity can be enhanced if the fraction of membrane-bound enzyme is increased and DAG has been shown to increase the affinity of PKC-bilayer binding by at least 1 order of magnitude (39). To test the possibility that alcohols promote PKC activity by increasing the fraction of bilayer-bound PKC, octanol was applied to the DMPC/DMPS/DO system and bilayer binding of PKC was detected by measuring fluorescence energy transfer from the Trp in PKC-alpha to dansyl-phosphatidylethanolamine (dansyl-PE) probes incorporated into the vesicles. Dansyl-PE at high concentration (>= 10 mol %) has been shown to alter membrane structure and in turn to activate PKC (39). In this experiment we used 2 mol % which did not affect PKC activity (data not shown).

In the absence of DO, the binding was poor and little fluorescence energy transfer was measurable (Fig. 5A). An assay of competitive binding between DMPC/DMPS (80/20) and DMPC/DMPS/DO (72.5/20/7.5) vesicles provided an estimate of the apparent Kd to be greater than 450 µM in the absence of DO (data not shown). This method measures the apparent Kd of reference vesicles (VR) in the absence and the presence of the vesicles of interest (VI). The apparent Kd,I of VI is estimated as [LI]/(Kd,RI/Kd,R-1), where [LI] is the concentration of VI and Kd,RI and Kd,R are the apparent dissociation constants of VR in the presence and absence of VI, respectively. When 3 mM octanol was added to DMPC/DMPS (80/20), Kd was estimated to be ~170 µM (Fig. 5A). LUVs were used in the fluorescence energy transfer experiments whereas MLVs were used in PKC activity assays shown in Fig. 1. About 10% of the total lipids are in the outermost layer of MLVs with which PKC is associated. With the 1 mM MLVs used in Fig. 1, PKC is mostly unbound to the bilayers in the absence of DO and octanol because the Kd (>450 µM) is much greater than the accessible MLV concentration (100 µM), whereas in the presence of 3 mM octanol some fraction of the enzyme is bound to the bilayer because the Kd (~170 µM) is close to the accessible MLV concentration. These results suggest that in the absence of DO, octanol may, at least in part, promote PKC activity by enhancing the membrane binding of the enzyme. They cannot account for the fact that the maximal activity in the presence of octanol is 2-4-fold greater than the maximal activity obtained with DO alone.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of octanol on binding of PKC to the membrane. Binding of PKC to the membrane was determined using fluorescence energy transfer from PKC to the probe dansyl-PE in DMPC/DMPS/DO LUVs. A, binding of PKC to DMPC/DMPS/DO = 80/20/0 as a function of total lipid concentration in the absence (black-triangle) and in the presence (triangle ) of 3 mM octanol. B, binding of PKC to DMPC/DMPS/DO = 72.5/20/7.5 as a function of total lipid concentration in the absence (black-triangle) and in the presence of 600 µM (triangle ) and 3 mM (open circle ) octanol. C, binding of PKC to DMPC/DMPS/DO = 65/20/15 as a function of total lipid concentration in the absence (black-triangle) and presence of 200 µM (triangle ) octanol. Figures are representative of two to five independent experiments.

In the presence of 7.5 mol % DO, the affinity of PKC binding to the bilayer was increased with the addition of octanol (Fig. 5B). The apparent Kd was reduced by about 2-fold with 0.6 mM octanol (from 5.7 to 3.3 µM) and by about 4-fold with 3 mM octanol (from 5.7 to 1.6 µM). Octanol activated PKC in this lipid system (data not shown) as it did in DMPC/DMPS/DO (65/20/15) and (55/20/25) (Fig. 1A). The ED50 was less than 0.5 mM octanol and 1 mM octanol was able to maximally stimulate PKC activity by more than 12-fold, about 4-fold higher than that induced by 25 mol % DO alone.

In DMPC/DMPS/DO (65/20/15), 200 µM octanol was able to increase the enzyme activity by 3-fold (Fig. 1A) but only slightly enhanced the affinity of PKC binding to the bilayers (Fig. 5C). A similar result was observed in the DMPC/DMPS/DO (55/20/25) system (data not shown), although the apparent dissociation constant Kd was so small (<= 2.5 µM) that changes in Kd would be in the range of errors of measurement.

Octanol Does Not Induce Micellar or Hexagonal II Phases-- PCs or PSs with acyl chains shorter than eight carbons can form micelles and eliminate the requirement for PS or DAG in activating PKC (40). Bilayers in the cubic phase or with a tendency to form the HII phase, but not the HII phase itself, have been proposed to activate PKC (21, 41). To test the hypothesis that alcohols activate PKC by inducing non-lamellar phases of the lipids, 31P NMR spectroscopy was employed to detect the isotropy of the DMPC/DMPS/DO systems with octanol. At 30 °C, a typical, broad anisotropic spectrum indicative of a lamellar structure of MLVs of DMPC/DMPS/DO (80/20/0), (65/20/15), and (55/20/25) was observed. A small, isotropic peak indicative of a slight contamination (3-5%) by SUV also was observed on occasion. No nonlamellar isotropic resonances were observed in any lipid system with the addition of different octanol concentrations up to the octanol aqueous solubility limit of 4.5 mM (data not shown). Interestingly, octanol acted similarly to DO in shifting the 31P resonance downfield and broadening the MLV spectrum. These results suggest that alcohol does not induce the phospholipids to form nonlamellar phases or regions of high bilayer curvature.

Octanol and Pentanol Change the Phase Behavior and Induce Lateral Heterogeneity in DMPC/DMPS System-- Another possible mechanism by which alcohols may mimic DAG in activating PKC is that they both may alter the phase behavior of the lipid bilayers. Lipid lateral domain heterogeneity has been related to PKC activation by DAG (19, 42). To investigate the effects of alcohols on the phase behavior of the lipid bilayers, we used DSC and examined the DMPC/DMPS system with octanol and pentanol (Fig. 6). DSC measures the excess heat capacity of the lipid system as a function of temperature and provides direct information about the lipid gel to liquid-crystalline phase transition temperature (Tm) and the enthalpy of the phase transition.


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of octanol and pentanol on excess heat capacity functions for DMPC/DMPS LUVs and PKCalpha activity in the lipids. The excess heat capacity with various concentrations (mole fractions in the lipids) of octanol (A) and pentanol (B) as a function of temperature was determined in DMPC/DMPS = 50/50 LUVs. The thermograms were up-scans from 2 to 40 °C at 10 °C/h. Lipids (5 mM) were hydrated in 20 mM MOPS, 100 mM KCl, 100 µM EGTA, pH 7.2. Onset (triangle ) and offset (black-triangle) temperatures of the gel-fluid phase transition are plotted as a function of octanol (C) and pentanol (D) mole fractions in the lipids. Lipid samples with octanol and pentanol were subsequently used for PKC activity measurements at 4 °C (open circle ) and 35 °C () and the results are plotted in E and F. The reaction times for 4 and 35 °C were 1 h and 2.5 min, respectively. PKC activity is normalized to the maximal activity at each temperature in each alcohol. Partition coefficients for octanol are 7.4 × 103 and 1.4 × 104 at 4 and 35 °C, respectively, and partition coefficients for pentanol are 350 and 600 at the two temperatures. Figures are representative of two to three independent experiments.

As octanol or pentanol concentration was increased up to chi octanol = 0.29 or chi pentanol = 0.27 in gel state lipids, the Tm decreased and the transition broadened. However, at higher octanol or pentanol concentrations the Tm continued to decrease but the transition peak retained its shape with the increase of octanol and became sharper with the increase of pentanol (Fig. 6, A and B). In the presence of pentanol the transition exhibited two maxima suggestive of possible phase separation. The onset and offset temperatures of the main transition rapidly decreased at lower pentanol concentration and at a much reduced rate above chi pentanol = 0.2 and 0.38 for onset and offset temperatures, respectively. The partial phase diagram, shown in Fig. 6D, is suggestive of possible lipid demixing in the presence of pentanol. A similar partial phase diagram for octanol is less clear (Fig. 6C), although demixing above chi octanol = 0.19-0.29 (onset) and 0.36 (offset) is suggested. The enthalpy change associated with the transition, obtained from the total area under the transition curve, did not vary significantly with the concentration of either alcohol (data not shown). DAG was omitted here to avoid the interference of DAG-induced alteration of lipid structure, which shares many features with the alcohol results shown here (19). Nonetheless, the effect of octanol also was tested in the DMPC/DMPS/DO and DPPC/DPPS/DO systems with 0, 15, and 25 mol % DO and results similar to those in Fig. 6 were observed (data not shown).

When PKC activity was measured over the same alcohol concentration range as used in the experiments described in the legends to Fig. 6, A and B, two effects resembled those of DAG on PKC activation previously reported (19, 42). First, with both gel (4 °C) and fluid (35 °C) state lipid bilayers, PKC activity exhibited a maximum at a pentanol concentration that resides roughly in the putative coexistence region (cf. Fig. 6, D with F). Second, a lower mole fraction of alcohol in the lipid was required to activate PKC and achieve maximal enzyme activity in gel state than in fluid state (Fig. 6, E and F).

The peak in PKC activity is more pronounced with pentanol than with octanol (cf. Fig. 6, E and F). It appears that in gel state lipids with octanol, the enzyme activity exhibits a plateau, and a decrease of PKC activity is not observed in either gel or fluid state lipids with octanol. However, Fig. 6, E and F, show that the dependence of PKC activity on chi octanol in the lipid is similar to that on chi pentanol in the lipid before the maximal enzyme activity is achieved. With 5 mM lipids, octanol concentrations above chi octanol = 0.42 in gel state (or 9 mM total octanol concentration, the highest in the experiment) were not accessible due to the aqueous solubility limit (4.5 mM) of octanol.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Here we report the activation of PKCalpha by several n-alcohols in a saturated lipid system (Fig. 1) and by octanol in both saturated and unsaturated lipid systems (Figs. 1A and 3). In both systems alcohols activate PKC synergistically with DO and more effectively than DO. PKC activity as a function of alcohol concentration in either saturated or unsaturated lipids resembles that as a function of DO.

As noted previously (19-20, 42-43), the mole % DAG required for maximal PKC activity is much higher in saturated versus unsaturated lipid systems. Although these concentrations would appear to be supraphysiological when expressed as a function of total cellular lipid, it must be remembered that the local concentration of DAG would be much higher at sites of phospholipase action where PKC might be activated. Similarly higher alcohol concentrations are required to activate PKC in the saturated systems (Figs. 1 and 3). Thus like other lipid-soluble modulators of PKC activity (31, 44), the concentrations of alcohols required depend on the lipid context.

Our results for octanol and heptanol in DMPC/DMPS/DO ((80-X)/20/X) are similar to those of Slater et al. (32) in POPC/brain PS/DO (76/20/4). However, our results for shorter chain alcohols (butanol to hexanol) demonstrate activation without DO and activation followed by inhibition with DO, whereas they observed only inhibition of PKC (10, 32). Some differences in lipid compositions (unsaturated mixed lipids versus saturated or unsaturated mixed lipids here), lipid vesicle types and concentrations (150 µM LUVs versus 1 mM MLVs here), and substrates (peptide corresponding to the consensus sequence of myelin basic protein versus histone here) exist between their studies and this one and could be the basis of the difference in the observations. Lester and Baumann (30) did observe a slight activation of rat brain PKC with ethanol in 100 µM egg PC/bovine spinal cord PS/liver DAG (80/20/10) vesicles using histone as substrate.

We have observed that octanol enhances the binding of PKC to lipid bilayers in both the absence and presence of DO (Fig. 5). This enhancement appears to account, at least partially, for PKC activation by octanol in the absence of DO. However, the increase in PKC activity with 3 mM octanol is at least 2 orders of magnitude greater than the basal activity whereas the increase of PKC-bilayer binding affinity is only 3-fold, suggesting that the increased binding is insufficient to explain the promotion of PKC activity by octanol. Similarly, in the presence of DO, binding of PKC to the bilayers is only slightly increased with low concentrations of octanol which dramatically activate PKC (cf. Figs. 1A and 5). It should be noted, however, that different lipid vesicles are used in the activity assays (MLVs) and bilayer binding measurements (LUVs) as well as different enzyme:lipid ratios (5 nM PKC with 1 mM total lipid in kinase assays versus 33 or 67 nM PKC with 3-400 µM lipid in bilayer binding assays). The enzyme:lipid ratio is higher in the bilayer binding assays under all conditions even with accounting for the MLV/LUV difference. Since a peak rather than a plateau occurs in PKC activity assays as a function of lipid concentration and composition (43), bilayer binding and activity cannot be compared quantitatively unless the assays are conducted under identical conditions and this was not possible here due to the differing sensitivities of the two assays.

One of the two major hypotheses for the mechanism of anesthetic actions argues for the existence of a specific binding site(s) in a protein for anesthetics (the specific protein binding model). Since (i) alcohols mimic DAG in activating PKC and enhancing the binding of PKC to lipid bilayers and (ii) DAG interacts directly with PKC by binding to one of the cysteine-rich domains on the enzyme, PKC would be an example of the specific protein binding model if alcohols bind to the DAG, or more specifically phorbol ester, the binding sites.

Activation of PKCalpha by alcohols does not seem to be attributable to the interaction of alcohols with the high affinity phorbol ester-binding site on PKCalpha , as shown in Fig. 4. No significant effect on PDB-PKCalpha binding is observed with octanol over a wide range of PDB concentrations (Fig. 4A). There is no competition between octanol and PDB in binding to PKCalpha over a range of octanol concentrations which dramatically enhance PKCalpha activity (Fig. 4B).

Slater et al. (32) observed that octanol enhances the interaction of the phorbol ester sapintoxin D with PKCalpha at the high affinity binding site. However, they also observed no effect of butanol on high affinity binding of sapintoxin D to PKCalpha . They proposed that DAG and alcohols compete for binding to a putative low affinity phorbol ester-binding site, and that high affinity binding of phorbol ester is in turn enhanced by DAG or long chain alcohols but not by short chain alcohols. They suggested that the activation of PKC by DAG or long chain alcohols resulted from enhancement of phorbol ester binding to the high affinity site on the enzyme.

An alternative explanation for the enhancement of high affinity phorbol ester binding is an increase in PKC bilayer association when DAG or octanol are present. The apparent dissociation constant (Kd,app) of phorbol esters from the high affinity site on PKCalpha is determined by the association of PKCalpha with the bilayer and the interaction of phorbol esters with bilayer-associated PKCalpha . If some of the enzyme is not bound to the bilayer, Kd,app will be greater than the Kd of phorbol ester with bilayer-bound PKCalpha and any compound that promotes the association of soluble PKCalpha with the bilayer will decrease Kd,app. On the other hand, if all of the enzyme is bound to the bilayer, Kd,app is the same as the Kd of phorbol ester from bilayer-bound PKC and would not be affected by any compound that facilitates the bilayer association process. The Kd,app of sapintoxin D and PDB binding to PKCalpha in a detergent/lipid mixed micellar system are ~2.5 and ~20 nM, respectively (45). However, the Kd,app of sapintoxin D from PKC (>= 100 nM) in the lipid system used by Slater et al. (32) (POPC/BPS = 4/1 molar ratio, 150 µM) is 40-fold greater than that in a micellar system, whereas the Kd,app of PDB from PKC (~20 nM) in our lipid system (POPC/POPS = 1/1 molar ratio, 1 mM) is close to that in the micellar system. This suggests that PKCalpha is not all bound to the bilayers under the conditions used in the experiments described by Slater et al. (32) but that it is mostly associated with the lipid system described here. In support of this conjecture, it has been shown that 20 mol % PS (used in the Slater et al. (32) report) was insufficient to support significant PKC binding to the POPC/POPS or egg PC/BPS systems, while 50 mol % PS (used in the phorbol ester binding experiments of Fig. 4) was able to facilitate binding of more than 75% of PKC to the bilayer (39, 46, 47). Octanol can increase the membrane binding of PKC in the absence and presence of DAG, as shown in Fig. 5, and DAG is known to promote significantly bilayer association of PKC (39).

To test the specific protein binding hypothesis for alcohol effects on PKC, Slater et al. (32) also used protamine sulfate and observed inhibition of PKC by alcohols, instead of activation as observed in the presence of lipids. Protamine sulfate is commonly used in place of lipids to monitor the lipid independent activity of PKC (48) and Slater et al. (32) suggested that the inhibitory effect involves the direction interaction between PKC and alcohols which attenuates a conformational change of PKC induced by interaction with protamine sulfate (32). It should be noted that protamine sulfate also can be phosphorylated by PKC and is sometimes used as a PKC substrate. We have used protamine sulfate to replace lipids and observed octanol effects on PKC activation in the presence and absence of histone. Interestingly, phosphorylation of protamine sulfate in the absence of histone is increased with octanol, whereas the total phosphorylation of protamine sulfate plus histone is decreased; the phosphorylation of histone in the presence of protamine sulfate is therefore decreased with octanol (data not shown). The mechanism of protamine sulfate activation of PKC is poorly understood and Orr and Newton (49) have shown that this activator does not induce the same conformational change in PKC as do lipid activators. Possible alternative interpretations of the inhibition of PKC by alcohols with protamine sulfate are disruption of essential protamine sulfate aggregates (50) by the alcohols or irreversible damage to PKC, as may occur with some organic solvents in the absence of lipids (16).

The other major hypothesis for the mechanism of anesthetic actions argues for nonspecific effects on the lipid bilayers (the general membrane perturbation model). In addition to direct binding to PKC, DAG plays an important role in changing the physical properties of bilayers that are important for PKC activation. A relationship between PKC activity and changes in bilayer physical properties induced by the DAG-mimicking alcohols would support the general membrane perturbation model.

31P NMR experiments did not reveal formation of any nonlamellar structures over the octanol concentration range used in our PKC activity assays, arguing that octanol does not activate PKC by inducing nonlamellar phases like micelles, cubic phase, or HII phase. Epand et al. (21) suggested that the HII phase itself does not activate PKC, but the propensity of the lipids to form HII does. This propensity, however, cannot be revealed by 31P NMR.

Another structural change that alcohols with carbon chains shorter than 7 or 8 may induce in lipid bilayers is interdigitation of the lipids (51). Alcohol-induced lipid interdigitation can be ruled out here for two reasons: 1) interdigitation only occurs in gel state lipids but many of our experiments were conducted with fluid state lipids; 2) more importantly, the main transition temperature monotonically decreases with alcohol (e.g. Fig. 6) rather than increases as observed with alcohol-induced interdigitation (51).

DSC experiments suggest that alcohols, like DAGs (19, 42), may promote domain formation/demixing in DMPC/DMPS systems (Fig. 6). In the case of pentanol, a maximal PKC activation was observed with alcohol mole fractions where maximal coexistence of distinct domains would exist. If these putative alcohol-induced domains are similar to DAG-induced domains in facilitating the binding/insertion of PKC to the membrane and subsequent PKC substrate or PKC-PKC aggregation, then a further common basis for understanding alcohol and DAG activation of PKC exists.

Although DAG can bind directly to PKC (reviewed in Ref. 16) and is well known to enhance PKC-bilayer association (39, 46), Dibble et al. (19, 42) have suggested that DAG also induces lateral heterogeneity in PC/PS mixtures and that this effect is important for PKC activation. It was suggested that DAG associates with PC and PS to form putative DAG-rich domains distinct from the DAG-poor domains. PKC activity is strongly correlated with the co-existence of the putative DAG-rich and DAG-poor domains, with maximal enzyme activity occurring at a DAG mole fraction that creates the maximal interface between the two domains. Three possible explanations were proposed for this correlation: 1) PKC might preferentially associate with one type of domain and cluster on the membrane surface, thus enhancing the probability of enzyme oligomerization which may relate to PKC activation; 2) PKC activation might be facilitated by the binding/insertion of the enzyme at the interface between coexisting DAG-rich and DAG-poor phases; 3) PKC might be sensitive to the DMPS/DO mole ratio with either the DO-rich or the DO-poor phase. Recent studies of PKC activity as a function of mole fraction of PS, lipid concentration, and enzyme concentration revealed an activity maximum rather than a plateau, consistent with the possibility that increased quantities of activating lipid domains serve to dilute out PKC-substrate and/or PKC-PKC aggregates on the lipid surface (43).

In summary, alcohols can both lower and replace the DAG requirement for PKC activation in part by enhancing the affinity of enzyme binding to the bilayers and also in a manner dependent upon bilayer composition. The latter effect, we suggest, is due to the alcohol-induced formation of certain types of lipid domains required for PKC activation.

    ACKNOWLEDGEMENT

We thank Dr. Jeffery Ellena for assistance with the NMR experiments.

    FOOTNOTES

* This work was supported by Health and Human Services Grants R01 GM31184, P01 GM 47525, and R01 GM 59205.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Member of the Biophysics Graduate Program at the University of Virginia.

§ To whom correspondence should be addressed: Dept. of Pharmacology, University of Virginia Health Sciences Center, Box 448, Charlottesville, VA 22908. Tel.: 804-924-5020; Fax: 804-982-3878; E-mail: jjs@virginia.edu.

    ABBREVIATIONS

The abbreviations used are: PKC, protein kinase C; DAG, diacylglycerol; DMPC, dimyristoylphosphatidylcholine; DMPS, dimyristoylphosphatidylserine; DO, dioleoyl-sn-glycerol; DOPC, dioleoylphosphatidylcholine; DOPS, dioleoylphosphatidylserine; DPPC, dipalmitoylphosphatidylcholine; DPPS, dipalmitoylphosphatidylserine; DSC, differential scanning calorimetry; LUV, large unilamellar vesicles; MLV, multilamellar vesicles; MOPS, 3-(N-morpholino)propanesulfonic acid; PC, phosphatidylcholine; PDBu, phorbol 12,13-dibutyrate; PE, phosphatidylethanolamine; POPC, 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcholine; POPS, 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylserine; PS, phosphatidylserine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Ueda, I., and Kamaya, H. (1984) Anesth. Analg. 63, 929-945[Free Full Text]
2. Franks, N. P., and Lieb, W. R. (1994) Nature 367, 607-614[CrossRef][Medline] [Order article via Infotrieve]
3. Hille, B. (1980) in Progress in Anesthesiology, Vol. 2: Molecular Mechanism of Anesthesia (Fink, B. R., ed) , pp. 1-5, Raven Press, New York
4. Dodson, B. A., and Moss, J. (1984) Mol. Cell. Biochem. 64, 97-103[Medline] [Order article via Infotrieve]
5. Shearman, M. S., Sekiguchi, K., and Nishizuka, Y. (1989) Pharmacol. Rev. 41, 211-237[Abstract]
6. Nishizuka, Y., Shearman, M. S., Oda, T., Berry, N., Shinomura, T., Asaoka, Y., Ogita, K., Koide, H., Uikkawa, U., Kishimoto, A., Kose, A., Saito, N., and Tanaka, C. (1991) in Elsevier Science Publisher (Gispen, W. H. , and Routtenberg, A., eds) , pp. 125-141, Elsevier Science Publisher B. V., Amsterdam, Netherlands
7. Huganir, R. L., and Greengard, P. (1990) Neuron 5, 555-567[CrossRef][Medline] [Order article via Infotrieve]
8. Hemmings, H. C. J., Nairn, A. C., McGuinness, T. L., Huganir, R. L., and Greengard, P. (1989) FASEB J. 3, 1583-1592[Abstract]
9. Hemmings, H. C. J., and Adamo, A. I. (1996) Anesthesiology 84, 652-662[CrossRef][Medline] [Order article via Infotrieve]
10. Slater, S. J., Cox, K. J., Lombardi, J. V., Ho, C., Kelly, M. B., Rubin, E., and Stubbs, C. D. (1993) Nature 364, 82-84[CrossRef][Medline] [Order article via Infotrieve]
11. Oda, A., Druker, B. J., Ariyoshi, H., Smith, M., and Salzman, E. W. (1995) Am. J. Physiol. 269, C118-C125[Abstract/Free Full Text]
12. Trudell, J. R., Costa, A. K., and Hubbell, W. L. (1991) Ann. N. Y. Acad. Sci. 625, 743-746[Medline] [Order article via Infotrieve]
13. Nishizuka, Y. (1992) Science 258, 607-614[Abstract/Free Full Text]
14. Dekker, L. V., and Parker, P. J. (1994) Trends Biochem. Sci. 19, 73-77[CrossRef][Medline] [Order article via Infotrieve]
15. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., and Nishizuka, Y. (1982) J. Biol. Chem. 257, 7847-7851[Abstract/Free Full Text]
16. Sando, J. J., Maurer, M. C., Bolen, E. J., and Grisham, C. M. (1992) Cell. Signal. 4, 595-609[CrossRef][Medline] [Order article via Infotrieve]
17. Bazzi, M. D., and Nelsestuen, G. L. (1991) Biochemistry 30, 7961-7969[CrossRef][Medline] [Order article via Infotrieve]
18. Yang, L., and Glaser, M. (1995) Biochemistry 34, 1500-1506[CrossRef][Medline] [Order article via Infotrieve]
19. Dibble, A. R., Hinderliter, A. K., Sando, J. J., and Biltonen, R. L. (1996) Biophys. J. 71, 1877-1890[Medline] [Order article via Infotrieve]
20. Bolen, E. J., and Sando, J. J. (1992) Biochemistry 31, 5945-5951[CrossRef][Medline] [Order article via Infotrieve]
21. Epand, R. M., Epand, R. F., Leon, B. T., Menger, F. M., and Kuo, J. F. (1991) Biosci. Rep. 11, 59-64[CrossRef][Medline] [Order article via Infotrieve]
22. Senisterra, G., and Epand, R. M. (1993) Arch. Biochem. Biophys. 300, 378-383[CrossRef][Medline] [Order article via Infotrieve]
23. Goldberg, E. M., Lester, D. S., Borchardt, D. B., and Zidovetzki, R. (1994) Biophys. J. 66, 382-393[Medline] [Order article via Infotrieve]
24. Trudell, J. R., Costa, A. K., and Csernansky, C. A. (1989) Biochem. Biophys. Res. Commun. 162, 45-50[CrossRef][Medline] [Order article via Infotrieve]
25. Moris, M. E., and McLaughlin, S. (1992) in Protein Kinase C, Current Concepts and Future Perspectives (Lester, D. , and Epand, R. M., eds) , pp. 157-180, Hills Horwood Limited, Chichester, England
26. Ho, C., Kelly, M. B., and Stubbs, C. D. (1994) Biochim. Biophys. Acta 1193, 307-315[Medline] [Order article via Infotrieve]
27. Bottner, M., and Winter, R. (1993) Biophys. J. 65, 2041-2046[Medline] [Order article via Infotrieve]
28. Jorgensen, K., Ipsen, J. H., Mouritsen, O. G., Bennett, D., and Zuckermann, M. J. (1991) Biochim. Biophys. Acta 1067, 241-253[Medline] [Order article via Infotrieve]
29. Mori, T., Takai, Y., Minakuchi, R., Yu, B., and Nishizuka, Y. (1980) J. Biol. Chem. 255, 8378-8380[Abstract/Free Full Text]
30. Lester, D. S., and Baumann, D. (1991) Eur. J. Pharmacol. 206, 301-308[CrossRef][Medline] [Order article via Infotrieve]
31. Hemmings, H. C. J., and Adamo, A. I. (1994) Anesthesiology 81, 147-155[Medline] [Order article via Infotrieve]
32. Slater, S. J., Kelly, M. B., Larkin, J. D., Ho, C., Mazurek, A., Taddeo, F. J., Yeager, M. D., and Stubbs, C. D. (1997) J. Biol. Chem. 272, 6167-6173[Abstract/Free Full Text]
33. Sando, J. J., and Young, M. C. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 2642-2646[Abstract/Free Full Text]
34. Morrison, W. R. (1964) Anal. Biochem. 7, 218-224
35. Bazzi, M. D., and Nelsestuen, G. L. (1987) Biochemistry 26, 115-122[CrossRef][Medline] [Order article via Infotrieve]
36. Zhang, F., and Rowe, E. S. (1992) Biochemistry 31, 2005-2011[CrossRef][Medline] [Order article via Infotrieve]
37. Kaminoh, Y., Tashiro, C., Kamaya, H., and Ueda, I. (1988) Biochim. Biophys. Acta 946, 215-220[Medline] [Order article via Infotrieve]
38. Slater, S. J., Ho, C., Kelly, M. B., Larkin, J. D., Taddeo, F. J., Yeager, M. D., and Stubbs, C. D. (1996) J. Biol. Chem. 271, 4627-4631[Abstract/Free Full Text]
39. Mosior, M., and Epand, R. M. (1993) Biochemistry 32, 66-75[CrossRef][Medline] [Order article via Infotrieve]
40. Walker, J. M., and Sando, J. J. (1989) Adv. Exp. Med. Biol. 255, 29-36[Medline] [Order article via Infotrieve]
41. Giorgione, J. R., Huang, Z., and Epand, R. M. (1998) Biochemistry 37, 2384-2392[CrossRef][Medline] [Order article via Infotrieve]
42. Hinderliter, A. K., Dibble, A. R., Biltonen, R. L., and Sando, J. J. (1997) Biochemistry 36, 6141-6148[CrossRef][Medline] [Order article via Infotrieve]
43. Sando, J. J., Chertihin, O. I., Owens, J. M., and Kretsinger, R. H. (1998) J. Biol. Chem. 273, 34022-34027[Abstract/Free Full Text]
44. Sando, J. J., and Chertihin, O. I. (1996) Biochem. J. 317, 583-588
45. Dimitrijevic, S. M., Ryves, W. J., Parker, P. J., and Evans, F. J. (1995) Mol. Pharmacol. 48, 259-267[Abstract]
46. Newton, A. C., and Keranen, L. M. (1994) Biochemistry 33, 6651-6658[CrossRef][Medline] [Order article via Infotrieve]
47. Medkova, M., and Cho, W. (1998) Biochemistry 37, 4892-4900[CrossRef][Medline] [Order article via Infotrieve]
48. Takai, Y., Kishimoto, A., Iwasa, Y., Kawahara, Y., Mori, T., and Nishizuka, Y. (1979) J. Biol. Chem. 254, 3692-3695[Abstract/Free Full Text]
49. Orr, J. W., and Newton, A. C. (1994) J. Biol. Chem. 269, 8383-8387[Abstract/Free Full Text]
50. Bazzi, M. D., and Nelsestuen, G. L. (1987) Biochemistry 26, 5002-5008[CrossRef][Medline] [Order article via Infotrieve]
51. Rowe, E. S., and Campion, J. M. (1994) Biophys. J. 67, 1888-1895[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. Huang and Z. Zuo
Isoflurane Induces a Protein Kinase C {alpha}-Dependent Increase in Cell-Surface Protein Level and Activity of Glutamate Transporter Type 3
Mol. Pharmacol., May 1, 2005; 67(5): 1522 - 1533.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Martinez, O. Vogler, J. Casas, F. Barcelo, R. Alemany, J. Prades, T. Nagy, C. Baamonde, P. G. Kasprzyk, S. Teres, et al.
Membrane Structure Modulation, Protein Kinase C{alpha} Activation, and Anticancer Activity of Minerval
Mol. Pharmacol., February 1, 2005; 67(2): 531 - 540.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. J. Rebecchi and S. N. Pentyala
Anaesthetic actions on other targets:protein kinase C and guanine nucleotide-binding proteins
Br. J. Anaesth., July 1, 2002; 89(1): 62 - 78.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, Y.-M. A.
Right arrow Articles by Sando, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, Y.-M. A.
Right arrow Articles by Sando, J. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement